nodes	percent_of_prediction	percent_of_DWPC	metapath
Tafluprost—PTGS2—Triamcinolone—atopic dermatitis	0.292	0.424	CbGbCtD
Tafluprost—PTGS2—Betamethasone—atopic dermatitis	0.251	0.364	CbGbCtD
Tafluprost—PTGS2—Dexamethasone—atopic dermatitis	0.146	0.212	CbGbCtD
Tafluprost—Eye discharge—Fluocinolone Acetonide—atopic dermatitis	0.0157	0.0612	CcSEcCtD
Tafluprost—Common cold—Fluocinolone Acetonide—atopic dermatitis	0.0142	0.0552	CcSEcCtD
Tafluprost—Conjunctival hyperaemia—Fluocinolone Acetonide—atopic dermatitis	0.00844	0.0328	CcSEcCtD
Tafluprost—Eye pruritus—Fluocinolone Acetonide—atopic dermatitis	0.0083	0.0322	CcSEcCtD
Tafluprost—Endophthalmitis—Fluocinolone Acetonide—atopic dermatitis	0.00779	0.0303	CcSEcCtD
Tafluprost—Eyelid oedema—Fluocinolone Acetonide—atopic dermatitis	0.00735	0.0286	CcSEcCtD
Tafluprost—Visual acuity reduced—Fluocinolone Acetonide—atopic dermatitis	0.00624	0.0242	CcSEcCtD
Tafluprost—Eye irritation—Pimecrolimus—atopic dermatitis	0.00607	0.0236	CcSEcCtD
Tafluprost—Asthma—Desonide—atopic dermatitis	0.0046	0.0179	CcSEcCtD
Tafluprost—Eye irritation—Fluocinolone Acetonide—atopic dermatitis	0.00435	0.0169	CcSEcCtD
Tafluprost—Conjunctival hyperaemia—Prednisolone—atopic dermatitis	0.0041	0.0159	CcSEcCtD
Tafluprost—Lacrimation increased—Fluocinolone Acetonide—atopic dermatitis	0.00403	0.0156	CcSEcCtD
Tafluprost—Cataract—Fluocinolone Acetonide—atopic dermatitis	0.0039	0.0151	CcSEcCtD
Tafluprost—Nasopharyngitis—Fluocinonide—atopic dermatitis	0.00386	0.015	CcSEcCtD
Tafluprost—Cataract—Mometasone—atopic dermatitis	0.00372	0.0145	CcSEcCtD
Tafluprost—Photophobia—Fluocinolone Acetonide—atopic dermatitis	0.00348	0.0135	CcSEcCtD
Tafluprost—Dry eye—Fluocinolone Acetonide—atopic dermatitis	0.00343	0.0133	CcSEcCtD
Tafluprost—Conjunctival hyperaemia—Betamethasone—atopic dermatitis	0.00342	0.0133	CcSEcCtD
Tafluprost—Conjunctival hyperaemia—Dexamethasone—atopic dermatitis	0.00342	0.0133	CcSEcCtD
Tafluprost—Nasopharyngitis—Pimecrolimus—atopic dermatitis	0.00336	0.0131	CcSEcCtD
Tafluprost—Asthma—Pimecrolimus—atopic dermatitis	0.00325	0.0126	CcSEcCtD
Tafluprost—Endophthalmitis—Betamethasone—atopic dermatitis	0.00316	0.0123	CcSEcCtD
Tafluprost—Endophthalmitis—Dexamethasone—atopic dermatitis	0.00316	0.0123	CcSEcCtD
Tafluprost—Eye pain—Fluocinolone Acetonide—atopic dermatitis	0.00298	0.0116	CcSEcCtD
Tafluprost—Cataract—Tacrolimus—atopic dermatitis	0.00296	0.0115	CcSEcCtD
Tafluprost—Cough—Desonide—atopic dermatitis	0.0028	0.0109	CcSEcCtD
Tafluprost—Endophthalmitis—Prednisone—atopic dermatitis	0.00275	0.0107	CcSEcCtD
Tafluprost—Photophobia—Tacrolimus—atopic dermatitis	0.00265	0.0103	CcSEcCtD
Tafluprost—Rhinitis—Pimecrolimus—atopic dermatitis	0.00261	0.0101	CcSEcCtD
Tafluprost—Dry eye—Tacrolimus—atopic dermatitis	0.0026	0.0101	CcSEcCtD
Tafluprost—Nervous system disorder—Desonide—atopic dermatitis	0.00257	0.00997	CcSEcCtD
Tafluprost—Visual acuity reduced—Betamethasone—atopic dermatitis	0.00253	0.00981	CcSEcCtD
Tafluprost—Visual acuity reduced—Dexamethasone—atopic dermatitis	0.00253	0.00981	CcSEcCtD
Tafluprost—Eye disorder—Pimecrolimus—atopic dermatitis	0.00243	0.00945	CcSEcCtD
Tafluprost—Nasopharyngitis—Fluocinolone Acetonide—atopic dermatitis	0.00241	0.00935	CcSEcCtD
Tafluprost—PTGS2—Fluocinonide—Desonide—atopic dermatitis	0.00238	0.165	CbGdCrCtD
Tafluprost—Nasopharyngitis—Mometasone—atopic dermatitis	0.0023	0.00893	CcSEcCtD
Tafluprost—Eye pain—Tacrolimus—atopic dermatitis	0.00227	0.00881	CcSEcCtD
Tafluprost—Asthma—Mometasone—atopic dermatitis	0.00222	0.00863	CcSEcCtD
Tafluprost—Vision blurred—Diphenhydramine—atopic dermatitis	0.00221	0.00858	CcSEcCtD
Tafluprost—Vision blurred—Dimenhydrinate—atopic dermatitis	0.00221	0.00858	CcSEcCtD
Tafluprost—Eye irritation—Prednisolone—atopic dermatitis	0.00211	0.00819	CcSEcCtD
Tafluprost—Nervous system disorder—Fluocinonide—atopic dermatitis	0.00208	0.00808	CcSEcCtD
Tafluprost—PTGS2—Calcium signaling in the CD4+ TCR pathway—CABIN1—atopic dermatitis	0.00201	0.0511	CbGpPWpGaD
Tafluprost—Cough—Pimecrolimus—atopic dermatitis	0.00198	0.00768	CcSEcCtD
Tafluprost—Urinary tract infection—Mometasone—atopic dermatitis	0.00193	0.00748	CcSEcCtD
Tafluprost—Rhinitis—Fluocinolone Acetonide—atopic dermatitis	0.00187	0.00725	CcSEcCtD
Tafluprost—PTGS2—Fluocinonide—Fluocinolone Acetonide—atopic dermatitis	0.00185	0.128	CbGdCrCtD
Tafluprost—Pruritus—Desonide—atopic dermatitis	0.00185	0.00719	CcSEcCtD
Tafluprost—Cataract—Hydrocortisone—atopic dermatitis	0.00185	0.00718	CcSEcCtD
Tafluprost—Nervous system disorder—Pimecrolimus—atopic dermatitis	0.00181	0.00704	CcSEcCtD
Tafluprost—Rhinitis—Mometasone—atopic dermatitis	0.00178	0.00693	CcSEcCtD
Tafluprost—Asthma—Tacrolimus—atopic dermatitis	0.00177	0.00687	CcSEcCtD
Tafluprost—Eye disorder—Fluocinolone Acetonide—atopic dermatitis	0.00174	0.00676	CcSEcCtD
Tafluprost—Cataract—Triamcinolone—atopic dermatitis	0.00174	0.00676	CcSEcCtD
Tafluprost—Dyspnoea—Pimecrolimus—atopic dermatitis	0.00165	0.0064	CcSEcCtD
Tafluprost—Headache—Desonide—atopic dermatitis	0.00164	0.00637	CcSEcCtD
Tafluprost—Dry eye—Hydrocortisone—atopic dermatitis	0.00162	0.00631	CcSEcCtD
Tafluprost—Cataract—Betamethasone—atopic dermatitis	0.00158	0.00613	CcSEcCtD
Tafluprost—Cataract—Dexamethasone—atopic dermatitis	0.00158	0.00613	CcSEcCtD
Tafluprost—Cough—Loratadine—atopic dermatitis	0.00157	0.00612	CcSEcCtD
Tafluprost—Urinary tract infection—Tacrolimus—atopic dermatitis	0.00153	0.00595	CcSEcCtD
Tafluprost—Vision blurred—Fluocinolone Acetonide—atopic dermatitis	0.00153	0.00594	CcSEcCtD
Tafluprost—Pruritus—Fluocinonide—atopic dermatitis	0.0015	0.00583	CcSEcCtD
Tafluprost—PTGS2—Fluocinonide—Mometasone—atopic dermatitis	0.00148	0.102	CbGdCrCtD
Tafluprost—Nervous system disorder—Loratadine—atopic dermatitis	0.00144	0.00561	CcSEcCtD
Tafluprost—Rhinitis—Tacrolimus—atopic dermatitis	0.00142	0.00551	CcSEcCtD
Tafluprost—Cough—Fluocinolone Acetonide—atopic dermatitis	0.00142	0.0055	CcSEcCtD
Tafluprost—Dry eye—Betamethasone—atopic dermatitis	0.00139	0.00539	CcSEcCtD
Tafluprost—Dry eye—Dexamethasone—atopic dermatitis	0.00139	0.00539	CcSEcCtD
Tafluprost—Cataract—Prednisone—atopic dermatitis	0.00138	0.00534	CcSEcCtD
Tafluprost—Cough—Mometasone—atopic dermatitis	0.00135	0.00525	CcSEcCtD
Tafluprost—PTGFR—GPCRs, Other—CXCR3—atopic dermatitis	0.00134	0.0339	CbGpPWpGaD
Tafluprost—Headache—Fluocinonide—atopic dermatitis	0.00133	0.00516	CcSEcCtD
Tafluprost—Eye disorder—Tacrolimus—atopic dermatitis	0.00132	0.00514	CcSEcCtD
Tafluprost—Pruritus—Pimecrolimus—atopic dermatitis	0.00131	0.00508	CcSEcCtD
Tafluprost—Nervous system disorder—Fluocinolone Acetonide—atopic dermatitis	0.0013	0.00504	CcSEcCtD
Tafluprost—Eye pain—Dexamethasone—atopic dermatitis	0.00121	0.00469	CcSEcCtD
Tafluprost—Eye pain—Betamethasone—atopic dermatitis	0.00121	0.00469	CcSEcCtD
Tafluprost—Headache—Diphenhydramine—atopic dermatitis	0.0012	0.00465	CcSEcCtD
Tafluprost—Headache—Dimenhydrinate—atopic dermatitis	0.0012	0.00465	CcSEcCtD
Tafluprost—Vision blurred—Tacrolimus—atopic dermatitis	0.00116	0.00451	CcSEcCtD
Tafluprost—Headache—Pimecrolimus—atopic dermatitis	0.00116	0.0045	CcSEcCtD
Tafluprost—PTGS2—Fluticasone Propionate—Fluocinonide—atopic dermatitis	0.00115	0.0797	CbGdCrCtD
Tafluprost—Dyspnoea—Mometasone—atopic dermatitis	0.00113	0.00438	CcSEcCtD
Tafluprost—PTGS2—Fluticasone Propionate—Fluocinolone Acetonide—atopic dermatitis	0.00112	0.0774	CbGdCrCtD
Tafluprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCL22—atopic dermatitis	0.00108	0.0275	CbGpPWpGaD
Tafluprost—Cough—Tacrolimus—atopic dermatitis	0.00108	0.00418	CcSEcCtD
Tafluprost—Asthma—Triamcinolone—atopic dermatitis	0.00104	0.00404	CcSEcCtD
Tafluprost—Nervous system disorder—Tacrolimus—atopic dermatitis	0.000987	0.00383	CcSEcCtD
Tafluprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCL27—atopic dermatitis	0.000965	0.0245	CbGpPWpGaD
Tafluprost—Pruritus—Fluocinolone Acetonide—atopic dermatitis	0.000937	0.00364	CcSEcCtD
Tafluprost—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKBIA—atopic dermatitis	0.00093	0.0236	CbGpPWpGaD
Tafluprost—Headache—Loratadine—atopic dermatitis	0.000923	0.00358	CcSEcCtD
Tafluprost—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FOXP3—atopic dermatitis	0.000911	0.0231	CbGpPWpGaD
Tafluprost—Dyspnoea—Tacrolimus—atopic dermatitis	0.000897	0.00348	CcSEcCtD
Tafluprost—Pruritus—Mometasone—atopic dermatitis	0.000894	0.00347	CcSEcCtD
Tafluprost—PTGS2—Fluticasone Propionate—Mometasone—atopic dermatitis	0.000893	0.0618	CbGdCrCtD
Tafluprost—PTGS2—Fluocinonide—Methylprednisolone—atopic dermatitis	0.000884	0.0612	CbGdCrCtD
Tafluprost—PTGS2—Fluocinonide—Betamethasone—atopic dermatitis	0.00087	0.0602	CbGdCrCtD
Tafluprost—PTGS2—Fluocinonide—Dexamethasone—atopic dermatitis	0.00087	0.0602	CbGdCrCtD
Tafluprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCL17—atopic dermatitis	0.000866	0.022	CbGpPWpGaD
Tafluprost—PTGS2—Fluocinonide—Triamcinolone—atopic dermatitis	0.00085	0.0588	CbGdCrCtD
Tafluprost—PTGFR—GPCRs, Other—CCR5—atopic dermatitis	0.000837	0.0212	CbGpPWpGaD
Tafluprost—Rhinitis—Triamcinolone—atopic dermatitis	0.000834	0.00324	CcSEcCtD
Tafluprost—Rhinitis—Methylprednisolone—atopic dermatitis	0.000832	0.00323	CcSEcCtD
Tafluprost—Headache—Fluocinolone Acetonide—atopic dermatitis	0.000829	0.00322	CcSEcCtD
Tafluprost—Eye disorder—Hydrocortisone—atopic dermatitis	0.000826	0.00321	CcSEcCtD
Tafluprost—PTGFR—GPCR ligand binding—CCL22—atopic dermatitis	0.000824	0.0209	CbGpPWpGaD
Tafluprost—Headache—Mometasone—atopic dermatitis	0.000792	0.00308	CcSEcCtD
Tafluprost—Eye disorder—Methylprednisolone—atopic dermatitis	0.000776	0.00301	CcSEcCtD
Tafluprost—PTGFR—G alpha (q) signalling events—NPS—atopic dermatitis	0.000765	0.0194	CbGpPWpGaD
Tafluprost—PTGFR—G alpha (q) signalling events—TAC1—atopic dermatitis	0.000765	0.0194	CbGpPWpGaD
Tafluprost—Vision blurred—Prednisolone—atopic dermatitis	0.000742	0.00288	CcSEcCtD
Tafluprost—PTGFR—GPCR ligand binding—CCL27—atopic dermatitis	0.000735	0.0186	CbGpPWpGaD
Tafluprost—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL4—atopic dermatitis	0.000734	0.0186	CbGpPWpGaD
Tafluprost—Pruritus—Tacrolimus—atopic dermatitis	0.000712	0.00276	CcSEcCtD
Tafluprost—Eye disorder—Betamethasone—atopic dermatitis	0.000705	0.00274	CcSEcCtD
Tafluprost—Eye disorder—Dexamethasone—atopic dermatitis	0.000705	0.00274	CcSEcCtD
Tafluprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.000698	0.0177	CbGpPWpGaD
Tafluprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—atopic dermatitis	0.000685	0.0174	CbGpPWpGaD
Tafluprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—atopic dermatitis	0.000685	0.0174	CbGpPWpGaD
Tafluprost—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL5—atopic dermatitis	0.000667	0.0169	CbGpPWpGaD
Tafluprost—PTGFR—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	0.000664	0.0168	CbGpPWpGaD
Tafluprost—PTGFR—GPCR ligand binding—CCL17—atopic dermatitis	0.000659	0.0167	CbGpPWpGaD
Tafluprost—Cough—Triamcinolone—atopic dermatitis	0.000632	0.00245	CcSEcCtD
Tafluprost—Headache—Tacrolimus—atopic dermatitis	0.00063	0.00245	CcSEcCtD
Tafluprost—Nervous system disorder—Hydrocortisone—atopic dermatitis	0.000615	0.00239	CcSEcCtD
Tafluprost—Eye disorder—Prednisone—atopic dermatitis	0.000614	0.00239	CcSEcCtD
Tafluprost—PTGFR—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.00058	0.0147	CbGpPWpGaD
Tafluprost—PTGS2—Overview of nanoparticle effects—CXCL8—atopic dermatitis	0.000578	0.0147	CbGpPWpGaD
Tafluprost—Nervous system disorder—Methylprednisolone—atopic dermatitis	0.000578	0.00225	CcSEcCtD
Tafluprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.000569	0.0144	CbGpPWpGaD
Tafluprost—Vision blurred—Prednisone—atopic dermatitis	0.000539	0.00209	CcSEcCtD
Tafluprost—PTGS2—Fluticasone Propionate—Methylprednisolone—atopic dermatitis	0.000533	0.0369	CbGdCrCtD
Tafluprost—PTGFR—GPCR ligand binding—CCL11—atopic dermatitis	0.000531	0.0135	CbGpPWpGaD
Tafluprost—Dyspnoea—Triamcinolone—atopic dermatitis	0.000527	0.00205	CcSEcCtD
Tafluprost—Nervous system disorder—Dexamethasone—atopic dermatitis	0.000526	0.00204	CcSEcCtD
Tafluprost—Nervous system disorder—Betamethasone—atopic dermatitis	0.000526	0.00204	CcSEcCtD
Tafluprost—PTGS2—Fluticasone Propionate—Betamethasone—atopic dermatitis	0.000525	0.0363	CbGdCrCtD
Tafluprost—PTGS2—Fluticasone Propionate—Dexamethasone—atopic dermatitis	0.000525	0.0363	CbGdCrCtD
Tafluprost—PTGS2—Fluticasone Propionate—Triamcinolone—atopic dermatitis	0.000513	0.0355	CbGdCrCtD
Tafluprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.000507	0.0129	CbGpPWpGaD
Tafluprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.000507	0.0129	CbGpPWpGaD
Tafluprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.000497	0.0126	CbGpPWpGaD
Tafluprost—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—atopic dermatitis	0.000474	0.012	CbGpPWpGaD
Tafluprost—Nervous system disorder—Prednisone—atopic dermatitis	0.000458	0.00178	CcSEcCtD
Tafluprost—Pruritus—Hydrocortisone—atopic dermatitis	0.000444	0.00172	CcSEcCtD
Tafluprost—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—atopic dermatitis	0.000443	0.0113	CbGpPWpGaD
Tafluprost—PTGFR—GPCR ligand binding—CCR3—atopic dermatitis	0.000433	0.011	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—CCL22—atopic dermatitis	0.000423	0.0107	CbGpPWpGaD
Tafluprost—Pruritus—Triamcinolone—atopic dermatitis	0.000418	0.00162	CcSEcCtD
Tafluprost—Pruritus—Methylprednisolone—atopic dermatitis	0.000417	0.00162	CcSEcCtD
Tafluprost—PTGFR—GPCR downstream signaling—CCL27—atopic dermatitis	0.000415	0.0105	CbGpPWpGaD
Tafluprost—Headache—Prednisolone—atopic dermatitis	0.000403	0.00156	CcSEcCtD
Tafluprost—PTGS2—Overview of nanoparticle effects—TNF—atopic dermatitis	0.000403	0.0102	CbGpPWpGaD
Tafluprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.000402	0.0102	CbGpPWpGaD
Tafluprost—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—atopic dermatitis	0.000394	0.01	CbGpPWpGaD
Tafluprost—Headache—Hydrocortisone—atopic dermatitis	0.000393	0.00153	CcSEcCtD
Tafluprost—PTGFR—GPCR ligand binding—NPS—atopic dermatitis	0.000386	0.0098	CbGpPWpGaD
Tafluprost—PTGFR—GPCR ligand binding—TAC1—atopic dermatitis	0.000386	0.0098	CbGpPWpGaD
Tafluprost—Pruritus—Dexamethasone—atopic dermatitis	0.000379	0.00147	CcSEcCtD
Tafluprost—Pruritus—Betamethasone—atopic dermatitis	0.000379	0.00147	CcSEcCtD
Tafluprost—PTGFR—GPCR ligand binding—CXCR3—atopic dermatitis	0.000379	0.00961	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—CCL27—atopic dermatitis	0.000377	0.00957	CbGpPWpGaD
Tafluprost—Headache—Triamcinolone—atopic dermatitis	0.00037	0.00144	CcSEcCtD
Tafluprost—Headache—Methylprednisolone—atopic dermatitis	0.000369	0.00143	CcSEcCtD
Tafluprost—PTGFR—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.000364	0.00923	CbGpPWpGaD
Tafluprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.000346	0.00878	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—CCL17—atopic dermatitis	0.000338	0.00858	CbGpPWpGaD
Tafluprost—Headache—Betamethasone—atopic dermatitis	0.000336	0.0013	CcSEcCtD
Tafluprost—Headache—Dexamethasone—atopic dermatitis	0.000336	0.0013	CcSEcCtD
Tafluprost—Pruritus—Prednisone—atopic dermatitis	0.00033	0.00128	CcSEcCtD
Tafluprost—PTGS2—Overview of nanoparticle effects—IL6—atopic dermatitis	0.000325	0.00824	CbGpPWpGaD
Tafluprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.000312	0.00791	CbGpPWpGaD
Tafluprost—PTGFR—GPCR ligand binding—CXCL10—atopic dermatitis	0.000306	0.00776	CbGpPWpGaD
Tafluprost—Headache—Prednisone—atopic dermatitis	0.000293	0.00114	CcSEcCtD
Tafluprost—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—atopic dermatitis	0.000287	0.00728	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—CXCL10—atopic dermatitis	0.000286	0.00726	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—CCL11—atopic dermatitis	0.000273	0.00692	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—FCER2—atopic dermatitis	0.000269	0.00682	CbGpPWpGaD
Tafluprost—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—atopic dermatitis	0.000267	0.00677	CbGpPWpGaD
Tafluprost—PTGFR—GPCR ligand binding—CCL5—atopic dermatitis	0.000263	0.00668	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—BDNF—atopic dermatitis	0.000257	0.00652	CbGpPWpGaD
Tafluprost—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—atopic dermatitis	0.000255	0.00647	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CCL22—atopic dermatitis	0.00025	0.00634	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—CCR3—atopic dermatitis	0.000245	0.00621	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—IL4—atopic dermatitis	0.000239	0.00606	CbGpPWpGaD
Tafluprost—PTGFR—GPCR ligand binding—CCR5—atopic dermatitis	0.000237	0.00602	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CCL27—atopic dermatitis	0.000223	0.00565	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—CCR3—atopic dermatitis	0.000222	0.00564	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—NPS—atopic dermatitis	0.000218	0.00554	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—TAC1—atopic dermatitis	0.000218	0.00554	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000214	0.00543	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—IL5—atopic dermatitis	0.000203	0.00515	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CCL17—atopic dermatitis	0.0002	0.00507	CbGpPWpGaD
Tafluprost—PTGS2—Aryl Hydrocarbon Receptor—TNF—atopic dermatitis	0.000198	0.00504	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—TAC1—atopic dermatitis	0.000198	0.00503	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—NPS—atopic dermatitis	0.000198	0.00503	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—CXCR3—atopic dermatitis	0.000194	0.00493	CbGpPWpGaD
Tafluprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000188	0.00478	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	0.000186	0.00473	CbGpPWpGaD
Tafluprost—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—atopic dermatitis	0.000186	0.00471	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—IL5—atopic dermatitis	0.000184	0.00467	CbGpPWpGaD
Tafluprost—PTGS2—C-MYB transcription factor network—CD4—atopic dermatitis	0.000183	0.00464	CbGpPWpGaD
Tafluprost—PTGS2—Selenium Micronutrient Network—IFNG—atopic dermatitis	0.000182	0.00463	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—KIF3A—atopic dermatitis	0.000178	0.00452	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—atopic dermatitis	0.000175	0.00444	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000173	0.00439	CbGpPWpGaD
Tafluprost—PTGS2—Selenium Micronutrient Network—IL1B—atopic dermatitis	0.000163	0.00413	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CMA1—atopic dermatitis	0.000161	0.00409	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CCL11—atopic dermatitis	0.000161	0.00409	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—CXCL10—atopic dermatitis	0.000157	0.00398	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—STAT6—atopic dermatitis	0.000151	0.00384	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—CCL5—atopic dermatitis	0.000149	0.00378	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—IFNG—atopic dermatitis	0.000144	0.00366	CbGpPWpGaD
Tafluprost—PTGFR—GPCR ligand binding—CXCL8—atopic dermatitis	0.000143	0.00364	CbGpPWpGaD
Tafluprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	0.000143	0.00363	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—CCL5—atopic dermatitis	0.000135	0.00343	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—CXCL8—atopic dermatitis	0.000134	0.0034	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—CCR5—atopic dermatitis	0.000134	0.0034	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CCR3—atopic dermatitis	0.000131	0.00333	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—IL1B—atopic dermatitis	0.000129	0.00327	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—IL2—atopic dermatitis	0.000128	0.00325	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	0.000128	0.00325	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—CCR5—atopic dermatitis	0.000122	0.00309	CbGpPWpGaD
Tafluprost—PTGS2—Selenium Micronutrient Network—TNF—atopic dermatitis	0.000118	0.003	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—NPS—atopic dermatitis	0.000117	0.00297	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—TAC1—atopic dermatitis	0.000117	0.00297	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	0.000115	0.00293	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CXCR3—atopic dermatitis	0.000115	0.00291	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—IL5—atopic dermatitis	0.000109	0.00276	CbGpPWpGaD
Tafluprost—PTGS2—Disease—GLB1—atopic dermatitis	9.9e-05	0.00251	CbGpPWpGaD
Tafluprost—PTGS2—Selenium Micronutrient Network—IL6—atopic dermatitis	9.53e-05	0.00242	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—TNF—atopic dermatitis	9.34e-05	0.00237	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CXCL10—atopic dermatitis	9.28e-05	0.00235	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—GLB1—atopic dermatitis	8.29e-05	0.0021	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—CXCL8—atopic dermatitis	8.11e-05	0.00206	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	8.03e-05	0.00204	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CCL5—atopic dermatitis	7.99e-05	0.00203	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ADSL—atopic dermatitis	7.95e-05	0.00202	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—IL2—atopic dermatitis	7.75e-05	0.00197	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—IL6—atopic dermatitis	7.54e-05	0.00191	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—NGF—atopic dermatitis	7.4e-05	0.00188	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—CXCL8—atopic dermatitis	7.36e-05	0.00187	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CCR5—atopic dermatitis	7.19e-05	0.00183	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—IL2—atopic dermatitis	7.04e-05	0.00179	CbGpPWpGaD
Tafluprost—PTGS2—Disease—SLC11A1—atopic dermatitis	6.63e-05	0.00168	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	6.35e-05	0.00161	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—NFKBIA—atopic dermatitis	6.1e-05	0.00155	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	6.04e-05	0.00153	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CXCL8—atopic dermatitis	4.35e-05	0.0011	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—IL2—atopic dermatitis	4.16e-05	0.00105	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—IL6—atopic dermatitis	4.14e-05	0.00105	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—MAPK8—atopic dermatitis	3.83e-05	0.000971	CbGpPWpGaD
Tafluprost—PTGS2—Disease—CCR5—atopic dermatitis	3.35e-05	0.000851	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PPARA—atopic dermatitis	2.69e-05	0.000683	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—IL6—atopic dermatitis	2.44e-05	0.00062	CbGpPWpGaD
Tafluprost—PTGS2—Disease—CD4—atopic dermatitis	2.11e-05	0.000534	CbGpPWpGaD
Tafluprost—PTGS2—Disease—IL6—atopic dermatitis	1.14e-05	0.000289	CbGpPWpGaD
